Immunoprecise Antibodies, a leader in full-service, therapeutic antibody discovery and development, announced a research partnership with Mila, a world-renowned research institute dedicated to artificial intelligence (AI) development and focused on deep learning optimization for AI and machine language learning.
ImmunoPrecise and Mila will collaborate on research and talent development initiatives as the Company continues to advance next generation innovation in therapeutics. The collaboration will leverage data and artificial intelligence to transform how novel therapeutics are discovered and developed. Founded by Professor Yoshua Bengio, co-recipient of the 2018 Turing Prize, the Mila Institute is recognized worldwide for its significant contributions in the field of deep learning and has established itself in the fields of language modeling, machine translation, object recognition, and generative design.
Recommended AI News: AndroVideo Inc. And The Open Security & Safety Alliance Spotlight First Commercially Available Camera(S) Built According To OSSA’s Technology Stack
“This partnership opens up an exciting opportunity for AI to tap into unexplored datasets generated by ImmunoPrecise’s effective and high-throughput therapeutic antibody discovery platforms, to contribute to the design of new therapeutics against life-threatening diseases that challenge humanity,” stated Mila Founder, Yoshua Bengio.
“This partnership reflects IPA’s deep-seeded commitment to innovation,” said Dr. Jennifer Bath, CEO of ImmunoPrecise. “Combining our efforts with the world-renowned talent at Mila catalyzes our advancements beyond the traditional life science model, as we continue to embrace the future of therapeutic discovery to accelerate the commercialization of life saving therapeutics.”
Recommended AI News: Vorboss Appoints Volta As Its Core Site To Support Fibre Network Build
This partnership comes on the heels of ImmunoPrecise engaging LaPorte Expert Conseil Inc., with whom the Company has recently completed a feasibility study for the design of a Good Manufacturing Practices (GMP) facility. ImmunoPrecise’s partnerships with Mila and LaPorte were facilitated by Montréal International, an economic promotion agency focused on the growth of Greater Montréal, as a part of Montréal International’s ongoing efforts to support ImmunoPrecise in leveraging unique life science and technology partnerships.
Recommended AI News: Matillion Unites Data Transformation Leaders To Discuss Data Architecture Complexities
Copper rod scrap buying Copper scrap recycling Metal waste reclaiming and processing
Copper cable stripping, Scrap metal ecological impact, Copper scrap licensing